Patents by Inventor Meilang Xue

Meilang Xue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of APC analogue for wound healing
    Patent number: 12214024
    Abstract: The invention relates to wound repair and healing, particularly to dermal or cutaneous wounds including but not limited to acute and chronic wounds, burns and ulcers.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: February 4, 2025
    Assignee: ZZ Biotech LLC
    Inventors: Meilang Xue, Christopher John Jackson
  • Treatment of inflammatory skin disorders
    Patent number: 11617785
    Abstract: The invention relates to methods of using an effective amount of activated protein C (APC) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: April 4, 2023
    Assignee: ZZ Biotech LLC
    Inventors: Christopher John Jackson, Meilang Xue
  • Treatment of abnormal cutaneous scarring
    Patent number: 11491214
    Abstract: The invention relates to the prevention and treatment of pathologic scars using APC or analogue thereof.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: November 8, 2022
    Assignee: ZZ BIOTECH LLC
    Inventors: Christopher John Jackson, Meilang Xue
  • INFLAMMATORY SKIN DISORDER TREATMENT
    Publication number: 20210268062
    Abstract: The invention relates to a method of minimising a symptom of dermatitis in an individual having a skin disease or condition comprising the administration of a TR47 related peptide, wherein the TR47 related peptide generally refers to a peptide having an N-terminal sequence NH2-NPND or NH2-NPNDKY, which is derived from the N-terminal sequence of the Met1-Arg46 deleted human PAR1 (protease activated receptor 1) sequence.
    Type: Application
    Filed: June 28, 2019
    Publication date: September 2, 2021
    Inventors: Christopher John JACKSON, Meilang XUE
  • TREATMENT OF INFLAMMATORY SKIN DISORDERS
    Publication number: 20200276281
    Abstract: The invention relates to methods of using an effective amount of activated protein C (APC) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.
    Type: Application
    Filed: May 21, 2020
    Publication date: September 3, 2020
    Inventors: Christopher John Jackson, Meilang Xue
  • TREATMENT OF ABNORMAL CUTANEOUS SCARRING
    Publication number: 20200108128
    Abstract: The invention relates to the prevention and treatment of pathologic scars using APC or analogue thereof.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 9, 2020
    Inventors: Christopher John JACKSON, Meilang XUE
  • USE OF APC ANALOGUE FOR WOUND HEALING
    Publication number: 20200000890
    Abstract: The invention relates to wound repair and healing, particularly to dermal or cutaneous wounds including but not limited to acute and chronic wounds, burns and ulcers.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Inventors: Meilang Xue, Christopher John Jackson
  • TREATMENT OF ABNORMAL CUTANEOUS SCARRING
    Publication number: 20190060421
    Abstract: The invention relates to the prevention and treatment of pathologic scars using APC or analogue thereof.
    Type: Application
    Filed: October 9, 2018
    Publication date: February 28, 2019
    Inventors: Christopher John Jackson, Meilang Xue
  • USE OF APC ANALOGUE FOR WOUND HEALING
    Publication number: 20180243383
    Abstract: The invention relates to wound repair and healing, particularly to dermal or cutaneous wounds including but not limited to acute and chronic wounds, burns and ulcers.
    Type: Application
    Filed: February 15, 2018
    Publication date: August 30, 2018
    Inventors: Meilang Xue, Christopher John Jackson
  • TREATMENT OF INFLAMMATORY SKIN DISORDERS
    Publication number: 20170080062
    Abstract: The invention relates to methods of using an effective amount of activated protein C (APC) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.
    Type: Application
    Filed: November 30, 2016
    Publication date: March 23, 2017
    Inventors: Christopher John Jackson, Meilang Xue
  • Treatment of abnormal cutaneous scarring
    Publication number: 20170042982
    Abstract: The invention relates to the prevention and treatment of pathologic scars using APC or analogue thereof.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 16, 2017
    Inventors: Christopher John Jackson, Meilang XUE
  • TREATMENT OF INFLAMMATORY SKIN DISORDERS
    Publication number: 20150150954
    Abstract: The invention relates to methods of using an effective amount of activated protein C (APC) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.
    Type: Application
    Filed: July 4, 2013
    Publication date: June 4, 2015
    Applicant: The University of Sydney
    Inventors: Christopher John Jackson, Meilang Xue
  • Treatment for Autoimmune and Inflammatory Conditions
    Publication number: 20080293631
    Abstract: The present invention provides methods for preventing the elevation of blood glucose levels, for preventing or delaying the onset of autoimmune and inflammatory diseases or glucose-associated conditions, and for preventing or reducing inflammation in individuals suffering from an autoimmune or inflammatory diseases, the methods comprising administering to subjects in need thereof an effective amount of activated Protein C or precursor Protein C.
    Type: Application
    Filed: January 9, 2006
    Publication date: November 27, 2008
    Inventors: Christopher John Jackson, Meilang Xue